Adverum Biotechnologies Stock Price on March 13, 2024
| ADVM Stock | USD 6.45 0.29 4.71% |
Below is the normalized historical share price chart for Adverum Biotechnologies extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adverum Biotechnologies stands at 6.45, as last reported on the 28th of November, with the highest price reaching 6.46 and the lowest price hitting 6.19 during the day.
If you're considering investing in Adverum Stock, it is important to understand the factors that can impact its price. Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0154, which signifies that the company had a -0.0154% return per unit of risk over the last 3 months. Adverum Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adverum Biotechnologies' Standard Deviation of 3.49, risk adjusted performance of (0.02), and Mean Deviation of 2.62 to double-check the risk estimate we provide.
At this time, Adverum Biotechnologies' Common Stock Shares Outstanding is very stable compared to the past year. As of the 28th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 247.9 M, while Other Stockholder Equity is likely to drop about 567.3 M. . At this time, Adverum Biotechnologies' Price Book Value Ratio is very stable compared to the past year. As of the 28th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price Earnings Ratio is likely to drop (0.68). Adverum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2014 | 200 Day MA 9.6991 | 50 Day MA 7.3533 | Beta 1.008 |
Adverum |
Sharpe Ratio = -0.0154
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADVM |
Estimated Market Risk
| 3.53 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Adverum Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding Adverum Biotechnologies to a well-diversified portfolio.
Price Book 0.931 | Enterprise Value Ebitda 0.099 | Price Sales 134.1761 | Shares Float 12.6 M | Wall Street Target Price 29.7143 |
Adverum Biotechnologies Main Headline on 13th of March 2024
Acquisition by Soparkar Peter of 21750 shares of Adverum Bio... by Soparkar Peter
Filed transaction by Adverum Biotechnologies Officer See Remarks Section. Grant, award or other acquisition pursuant to Rule 16b-3
Adverum Biotechnologies Valuation on March 13, 2024
It is possible to determine the worth of Adverum Biotechnologies on a given historical date. On March 13, 2024 Adverum was worth 18.0 at the beginning of the trading date compared to the closed value of 18.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adverum Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Adverum Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adverum Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adverum Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 18.20 | 19.10 | 17.80 | 18.10 | 89,082 | |
03/13/2024 | 18.00 | 18.30 | 17.60 | 18.00 | 164,347 |
| 17.80 | 18.20 | 16.70 | 17.30 | 162,721 |
| Backtest Adverum Biotechnologies | | | Adverum Biotechnologies History | | | Adverum Biotechnologies Valuation | Previous | Next |
Adverum Biotechnologies Trading Date Momentum on March 13, 2024
| On March 14 2024 Adverum Biotechnologies was traded for 17.30 at the closing time. The top price for the day was 18.20 and the lowest listed price was 16.70 . The trading volume for the day was 162.7 K. The trading history from March 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.89% . The overall trading delta against the current closing price is 12.50% . |
Adverum Biotechnologies Fundamentals Correlations and Trends
By evaluating Adverum Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adverum Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adverum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Adverum Biotechnologies Stock history
Adverum Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adverum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adverum Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adverum Biotechnologies stock prices may prove useful in developing a viable investing in Adverum Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.1 M | 18.4 M | |
| Net Loss | -139.1 M | -146 M |
Adverum Biotechnologies Quarterly Net Working Capital |
|
Adverum Biotechnologies Stock Technical Analysis
Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Adverum Biotechnologies Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Adverum Biotechnologies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Adverum Biotechnologies November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adverum Biotechnologies stock market strength indicators, traders can identify Adverum Biotechnologies entry and exit signals to maximize returns
Adverum Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adverum Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adverum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adverum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.08) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.70) | Return On Assets (0.30) | Return On Equity (0.76) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.